Copyright
©2014 Baishideng Publishing Group Inc.
World J Stem Cells. Jul 26, 2014; 6(3): 278-287
Published online Jul 26, 2014. doi: 10.4252/wjsc.v6.i3.278
Published online Jul 26, 2014. doi: 10.4252/wjsc.v6.i3.278
Delivery system | Administration site | Localization, timing | Delivery system | Ref. | |
Merits | Demerits | ||||
Cell-sheet | Adventitia of abdominal aorta | Adventitia, 4 wk after implantation | High targeting ability | Invasive procedure by laparotomy | [51] |
iv | Tail vein | Media and/or adventitia, at 4 wk | Least invasive | Low targeting ability and trapping in other tissue | [53] |
iv | Tail vein | Data not shown | Least invasive | Low targeting ability and trapping in other tissue | [54] |
Catheter | Clamped endovascular | Intima 1 wk after injection | Less invasive and high targeting ability | Requirement of a surgical procedure or advanced catheter intervention | [56] |
Catheter | Clamped endovascular | Media 3 wk after injection | Less invasive and high targeting ability | Requirement of a surgical procedure or advanced catheter intervention | [57] |
Direct injection | Injured aortic wall | Aortic wall, 1 wk after injection | High targeting ability | Risk of rupture | [58] |
- Citation: Yamawaki-Ogata A, Hashizume R, Fu XM, Usui A, Narita Y. Mesenchymal stem cells for treatment of aortic aneurysms. World J Stem Cells 2014; 6(3): 278-287
- URL: https://www.wjgnet.com/1948-0210/full/v6/i3/278.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v6.i3.278